AlphaYouANTX: Trenor Cameron C. III discloses securities transactions
By AlphaYouPublished Form 4
Trenor Cameron C. III
Reporting filer
Trenor Cameron C. III reported Grant or award in AN2 Therapeutics, Inc.: 116667 units of Common Stock, dated 2026-09-15. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 16, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Trenor Cameron C. III | 2026-09-15 | A | Grant or award | 116667 | 0 | 116,667 | 1 day | Filed terms
|
| Stock Option (right to by) (derivative) | Trenor Cameron C. III | 2026-09-15 | A | Grant or award | 233333 | 0 | 233,333 | 1 day | Filed terms
|
Common Stock
- Owner
- Trenor Cameron C. III
- Date
- 2026-09-15
- Code
- A
- Action
- Grant or award
- Quantity
- 116667
- Price
- 0
- Following holdings
- 116,667
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 116667
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 116667
- direct Or Indirect Ownership: D
Stock Option (right to by) (derivative)
- Owner
- Trenor Cameron C. III
- Date
- 2026-09-15
- Code
- A
- Action
- Grant or award
- Quantity
- 233333
- Price
- 0
- Following holdings
- 233,333
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (right to by)
- conversion Or Exercise Price: 5.36
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 233333
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-09-14
- underlying Security Title: Common Stock
- underlying Security Shares: 233333
- shares Owned Following Transaction: 233333
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Trenor Cameron C. III: Chief Medical Officer.
- F1: Represents restricted stock units ("RSUs") which vest as follows: 10,400 RSUs vest on January 1, 2027, prorated from August 24, 2026, the vesting start date, and the remaining RSUs vest in equal annual installments on each January 1, 2028, January 1, 2029 and January 1, 2030, subject to the Reporting Person's continuous service through each applicable vesting date.
- F2: The shares subject to the stock option vest as follows: 25% of the shares vest on August 24, 2027 and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.